Live Breaking News & Updates on Therapeutics Incorporated

Stay updated with breaking news from Therapeutics incorporated. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Corcept Therapeutics (NASDAQ:CORT) Sets New 1-Year High at $34.39

Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Free Report) reached a new 52-week high during trading on Wednesday . The company traded as high as $34.39 and last traded at $34.20, with a volume of 520210 shares trading hands. The stock had previously closed at $32.87. Wall Street Analyst Weigh In A number of […] ....

United States , Gary Charles Robb , Sean Maduck , Securities Exchange Commission , Burney Co , Corcept Therapeutics Incorporated , Cetera Advisors , Jacobs Levy Equity Management Inc , Hancock Whitney Corp , Janus Henderson Group , Get Free Report , Corcept Therapeutics , Exchange Commission , Whitney Corp , Levy Equity Management , Henderson Group , Therapeutics Incorporated , Corcept Therapeutics Daily ,

Corcept Therapeutics Incorporated (NASDAQ:CORT) Insider Sells $150,900.00 in Stock

Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Free Report) insider Joseph Douglas Lyon sold 5,000 shares of the firm’s stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $30.18, for a total transaction of $150,900.00. Following the completion of the transaction, the insider now owns 7,314 […] ....

United States , Joseph Douglas Lyon , Investment Advisers , Corcept Therapeutics Incorporated , Securities Exchange Commission , Fintrust Capital Advisors , Solutions Inc , Get Free Report , Exchange Commission , Douglas Lyon , Corcept Therapeutics , Therapeutics Incorporated , Capital Management , Trust Capital Advisors , Corcept Therapeutics Daily ,

Corcept Therapeutics (NASDAQ:CORT) Stock Rating Reaffirmed by HC Wainwright

Corcept Therapeutics (NASDAQ:CORT – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at HC Wainwright in a research report issued on Wednesday, Benzinga reports. They presently have a $40.00 price target on the biotechnology company’s stock. HC Wainwright’s price objective would indicate a potential upside of 28.16% from the stock’s current […] ....

United States , Sean Maduck , Joseph Douglas Lyon , Fintrust Capital Advisors , Solutions Inc , Securities Exchange Commission , Corcept Therapeutics Incorporated , Investment Advisers , Corcept Therapeutics , Get Free Report , Exchange Commission , Capital Management , Trust Capital Advisors , Therapeutics Incorporated , Corcept Therapeutics Daily ,

Corcept Therapeutics' (CORT) "Buy" Rating Reaffirmed at HC Wainwright

Corcept Therapeutics (NASDAQ:CORT – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at HC Wainwright in a report released on Wednesday, Benzinga reports. They presently have a $40.00 price target on the biotechnology company’s stock. HC Wainwright’s target price points to a potential upside of 28.16% from the stock’s previous close. A […] ....

United States , Danieln Swisher Jr , Sean Maduck , Clearbridge Investments , Corcept Therapeutics Company Profile , Norden Group , Jacobs Levy Equity Management Inc , Corcept Therapeutics Incorporated , Norges Bank , Jupiter Asset Management Ltd , Securities Exchange Commission , Corcept Therapeutics , Get Free Report , Exchange Commission , Director Daniel , Levy Equity Management , Asset Management , Therapeutics Incorporated , Corcept Therapeutics Daily ,

Corcept Therapeutics Incorporated (NASDAQ:CORT) Insider Gary Charles Robb Sells 11,000 Shares of Stock

Corcept Therapeutics Incorporated (NASDAQ:CORT) Insider Gary Charles Robb Sells 11,000 Shares of Stock
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United States , Gary Charles Robb , Jacobs Levy Equity Management Inc , Clearbridge Investments , Corcept Therapeutics Incorporated , Jupiter Asset Management Ltd , Norden Group , Norges Bank , Get Free Report , Corcept Therapeutics , Therapeutics Incorporated , Levy Equity Management , Asset Management , Corcept Therapeutics Daily ,